Sector Alpha Week of 2026-09-11
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-11

Bannari Amman Sugars Ltd

BANARISUG
Sugar

Bannari Amman Sugars Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

The sharpest disagreement: annual EPS moved +41.3% against a −5.8% price move — the market has not yet caught up with the delivery.

The price is in a downtrend (10 weeks in) while the P/E sits at the 82nd percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −173.3% year on year, and 301% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Turning around
fundamental trajectory, 12 quarters
Price
₹3,518
−5.8% 1Y
P/E
36.2×
82nd pctile
of its own 10-year range
Revenue (Jun 26)
₹172 Cr
−58.9% YoY
Profit (Jun 26)
₹−11.0 Cr
−173.3% YoY
Operating margin
−3.0%
−12.0 pp YoY
ROCE
9%
FY26
ROIC
7.5%
vs WACC 12.0% → −4.5 pp
Cash conversion
301%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Bannari Amman Sugars Ltd trades at ₹3,518, in a downtrend and 10 weeks into that stage. That is −2.7% against its own 200-day average. It sits at 22% of a 52-week range of ₹3,378 to ₹4,020. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks.

Today the stock is in a downtrend — week 10 of stage 4. At ₹3,518 it trades −2.7% versus its 200-day average and sits at 22% of its 52-week range (₹3,378–₹4,020).

Sep 26: ₹3,518 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−2.7% versus the 200-day line, week 10 of stage 4
Price50-day avg200-day avg
S4S2S4S1₹4,468₹3,887₹3,305₹2,724₹2,142₹3,518₹3,614Sep 23Jun 24Mar 25Jan 26Sep 26
S4S2S4S1₹4,468₹3,887₹3,305₹2,724₹2,142₹3,518₹3,614Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (554 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Mar 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.5 years the stock moved +190% while the NIFTY 500 moved +267% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 4 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Bannari Amman Sugars Ltd trades at 36.2× P/E, at the pricey end of its own range (82nd percentile). Its long-run median P/E is 24.9×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 36.2× is at the pricey end of its own range (82nd percentile), against a long-run median of 24.9× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 36.2× vs a 24.9× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.4-year window; loss-period spikes above 59× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
at the pricey end of its own range (82nd percentile)
P/EMedianEPS (TTM) (quarterly)
63.0×₹15549.0×₹11735.0×₹77.721.0×₹38.97.0×₹0.0×36.20×₹97Apr 16Nov 18Jul 21Mar 24Sep 26
63.0×₹15549.0×₹11735.0×₹77.721.0×₹38.97.0×₹0.0×36.20×₹97Apr 16Jul 21Sep 26
PEG 0.77 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Computed here as quarter-end P/E ÷ trailing-twelve-month EPS growth (only quarters with positive growth), because a reported quarterly PEG is not held for this stock. Last 6 quarters.
below 1.0, the growth looks cheap against the multiple
PEGPEG = 1.0
3.3×2.5×1.7×0.9×0.1××0.77×Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q4 FY26
3.3×2.5×1.7×0.9×0.1××0.77×Q2 FY24Q4 FY24Q4 FY26
P/E
36.2×
82nd percentile of 10y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved +41.3% against a −5.8% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the +14.6%/yr price move, ~+7.6%/yr came from earnings growth and ~+7.0 pp from the multiple (expanding); over 10y, of the +6.2%/yr price move, ~−0.3%/yr came from earnings growth and ~+6.5 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Turning around

Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Bannari Amman Sugars Ltd reads as turning around on its fundamental arc. Turning around — profit growth swung from −32.0% at the trough to +8.0% off a 5-quarter-old trough, ROCE holding at 9.0%. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +6.9% in FY26, profit +41.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn. Turnaround-year spikes shown pinned (▲).
Revenue YoYProfit YoYEPS YoY
63%327%40%229%16%130%−7.1%31%−30%−67%%%6.9%41%FY16FY21FY26
63%327%40%229%16%130%−7.1%31%−30%−67%%%6.9%41%FY16FY21FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit accelerating
RevenueProfitEPS
28%63%13%33%−3.1%2.6%−19%−28%−34%−58%%%−7.6%8%7.3%Sep 23Dec 24Jun 26
28%63%13%33%−3.1%2.6%−19%−28%−34%−58%%%−7.6%8%7.3%Sep 23Dec 24Jun 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
18%16%13%11%8.0%%9%Sep 23Mar 24Dec 24Sep 25Jun 26
18%16%13%11%8.0%%9%Sep 23Dec 24Jun 26
Revenue growth
Flat
latest −7.6% · span −29.9% to +23.8%
Profit growth
Rising
latest +8.0% · span −49.7% to +54.9%
EPS growth
Rising
latest +7.3% · span −49.4% to +54.9%
ROCE
Stuck low
latest 9.0% · span 8.7%–17.4%

Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+6.9%−8.8%+4.2%+2.8%
Profit+41.0%+1.2%+10.0%+16.5%
EPS+41.3%+1.0%+9.9%+15.6%
Share price−5.8%+7.7%+14.6%+6.2%
Revenue YoY (Jun 26)
−58.9%
latest quarter vs a year ago
Profit YoY (Jun 26)
−173.3%
latest quarter vs a year ago
Revenue 10y
2.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

35.4/100 — rank 16 of 21 in Sugar · 100% evidence confidence

Bannari Amman Sugars Ltd scores 35.4 out of 100 against the 21 companies it is compared with in Sugar, ranking 16. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 11 + 10.2 + 9.3 + 4.9 = 35.4. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Bannari Amman Sugars Ltd reported ₹172 Cr of revenue in the Jun 26 quarter, −58.9% year on year. Over 10 years it has compounded at 2.8% a year. The last full year, FY26, came in at ₹1,917 Cr. The last four reported quarters add to ₹1,670 Cr.

FY26 revenue came in at ₹1,917 Cr (+6.9% on the year), capping 10 years at 2.8% compound. The latest quarter (Jun 26) printed ₹172 Cr, −58.9% year on year.

FY26 revenue ₹1,917 Cr (+6.9% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
2.8% a year over 10 years
RevenueYoY growth
2.7k63%2.0k40%1.4k16%682−7.1%0−30%₹ Cr%₹1,9176.9%FY16FY21FY26
2.7k63%2.0k40%1.4k16%682−7.1%0−30%₹ Cr%₹1,9176.9%FY16FY21FY26
Jun 26: ₹172 Cr (−58.9% YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
82962%62230%415−3.0%207−35%0−68%₹ Cr%₹172−58.9%Sep 23Dec 24Jun 26
82962%62230%415−3.0%207−35%0−68%₹ Cr%₹172−58.9%Sep 23Dec 24Jun 26

Pace check: the last four quarters averaged −7.0% growth against the decade's 2.8% — the current year is running slower than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew −7.6% over the last 4 quarters against −12.7%/yr over the last 8 — accelerating; TTM profit +8.0% vs −8.3%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Bannari Amman Sugars Ltd's operating margin is −3.0% in the Jun 26 quarter, −12.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0% to 23.0%. The current quarter is running below every full year in that window.

The latest quarter's operating margin is −3.0%, −12.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0%–23.0%.

🚨 Why the margin moved: operating margin went −11.7 pp year on year while gross margin went +3.5 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY26: 10.0% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 13-year window.
within a 10.0–23.0% band over 13 years
operating marginYoY change (pp)
24%7.2%20%2.9%17%−1.5%13%−5.8%9.0%−10%%%10%−2%FY14FY20FY26
24%7.2%20%2.9%17%−1.5%13%−5.8%9.0%−10%%%10%−2%FY14FY20FY26
Jun 26: −3.0% operating margin (−12.0 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
18%7.4%12%2.2%6.5%−3.0%1.0%−8.2%−4.5%−13%%%−3%−12%Sep 23Dec 24Jun 26
18%7.4%12%2.2%6.5%−3.0%1.0%−8.2%−4.5%−13%%%−3%−12%Sep 23Dec 24Jun 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Bannari Amman Sugars Ltd posted a net loss of ₹11.0 Cr in the Jun 26 quarter. Full-year FY26 profit was ₹148 Cr. The 10-year compound rate is 16.5%. That loss is 6.4% of the quarter's revenue. The same quarter a year earlier earned ₹15.0 Cr. 1 of the last 12 reported quarters were loss-making.

Jun 26 profit was ₹−11.0 Cr, −173.3% year on year. On the full year, FY26 printed ₹148 Cr (+41.0%), and the 10-year compound rate is 16.5%.

FY26 profit ₹148 Cr (+41.0% YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
16.5% a year over 10 years
Net profitYoY growth
1643,351%1232,441%821,530%41619%0−291%₹ Cr%₹14841%FY16FY21FY26
1643,351%1232,441%821,530%41619%0−291%₹ Cr%₹14841%FY16FY21FY26
Jun 26: ₹−11.0 Cr (−173.3% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
74176%5182%29−12%6−105%−17−199%₹ Cr%₹−11−173.3%Sep 23Dec 24Jun 26
74176%5182%29−12%6−105%−17−199%₹ Cr%₹−11−173.3%Sep 23Dec 24Jun 26

🚨 Why profit moved: revenue contributed −58.9% and the margin −12.0 pp — the quarter was revenue-led despite a thinner margin.

Pace comparison, last four quarters: profit −15.3% vs revenue −7.0%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 301% of Bannari Amman Sugars Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹514 Cr of operating cash against ₹148 Cr of profit. After ₹112 Cr of capital spending, ₹402 Cr was left as free cash.

FY26: operating cash of ₹514 Cr against reported profit of ₹148 Cr, leaving free cash of ₹402 Cr after ₹112 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 301% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO ₹514 Cr vs profit ₹148 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution.
301% of 3-year profit arrived as cash
Operating cashNet profitFree cash
714463211−41−292₹ Cr₹514₹148₹402FY16FY21FY26
714463211−41−292₹ Cr₹514₹148₹402FY16FY21FY26
FY26: CFO = 347% of profit (three-year rate 301%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash; outlier years shown pinned.
Conversion100%
344%184%24%−137%−297%%300%FY16FY21FY26
344%184%24%−137%−297%%300%FY16FY21FY26

Why conversion sits at 301%: the cash cycle tightened 218 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 1.8× depreciation over three years, so the next section's job is to check what that build-out is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Bannari Amman Sugars Ltd's cash conversion cycle runs 138 days in FY26, down from 356 days in FY21. Capital spending ran ₹329 Cr over the last 3 years. At FY26 sales of ₹1,917 Cr each day of that cycle holds about ₹5.3 Cr, so roughly ₹725 Cr sits inside the business at any moment.

FY26: debtors at 6 days, inventory at 142 days — roughly 4.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 138 days, tighter than FY21's 356.

The full loop: cash goes out to suppliers and production on day 0; stock waits 142 days to sell; customers pay about 6 days after that; and suppliers themselves are paid at 9 days — netting out to the 138-day cycle.

In money terms: at FY26 sales of ₹1,917 Cr, each day of the cycle holds about ₹5.3 Cr — so the 138-day loop keeps roughly ₹725 Cr sitting inside the business at any moment.

FY26: a 138-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 13-year window.
−218 days vs FY21
Cash cycleInventory daysDebtor daysPayable days
1,6651,219774329−117days138d142d6d9dFY14FY17FY20FY23FY26
1,6651,219774329−117days138d142d6d9dFY14FY20FY26

On the investment side: capital spending of ₹329 Cr over the last 3 fiscal years against ₹178 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹106 Cr (FY26) — capacity paid for but not yet earning.

FY26: capex ₹112 Cr, work-in-progress ₹106 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
a build-out
CapexWork-in-progress
298224149750₹ Cr₹112₹106FY16FY18FY21FY23FY26
298224149750₹ Cr₹112₹106FY16FY21FY26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.

Bannari Amman Sugars Ltd earns a ROCE of 9% in FY26. That is up from a trough of 4% in FY15. Return on invested capital clears the cost of that capital by −4.5 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 7.7% net margin on 0.89× asset turns.

FY26 ROCE is 9%, recovered from a FY15 trough of 4% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY26): 7.7% net margin × 0.89× asset turns × 1.13× balance-sheet leverage ≈ 7.7% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 7.5% − 12.0% = a −4.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY26: ROCE 9% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 13-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY15's 4%
ROCEROIC (annual)WACC
13%10%8.0%5.7%3.4%%9%8.4%FY14FY20FY26
13%10%8.0%5.7%3.4%%9%8.4%FY14FY20FY26
Q4 FY26: ROCE 8.8% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
16%13%10%7.1%4.2%%8.8%7.9%Q1 FY24Q2 FY25Q4 FY26
16%13%10%7.1%4.2%%8.8%7.9%Q1 FY24Q2 FY25Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Bannari Amman Sugars Ltd carries total debt of ₹9.0 Cr against shareholder equity of ₹1,913 Cr as of Mar 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 0.68 in FY22 to 0.00 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹9.0 Cr against shareholder equity of ₹1,913 Cr — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 0.68 (FY22) to 0.00 (FY26). The returns on this page are earned, not borrowed.

FY26: debt ₹9.0 Cr at 0.00× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
1.0k0.7×7780.5×5190.3×2590.1×0−0.1×₹ Cr×₹90.00×FY22FY24FY26
1.0k0.7×7780.5×5190.3×2590.1×0−0.1×₹ Cr×₹90.00×FY22FY24FY26
Mar 26: debt ₹9.0 Cr, debt-to-equity 0.00 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
6270.4×4710.3×3140.2×1570.1×00.0×₹ Cr×₹90.00×Jun 23Sep 24Mar 26
6270.4×4710.3×3140.2×1570.1×00.0×₹ Cr×₹90.00×Jun 23Sep 24Mar 26
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

No holder of Bannari Amman Sugars Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.0 points over the same window, to 0.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: +0.0 points over 8 quarters to 58.7%; Foreign institutions: +0.0 points over 8 quarters to 0.3%; Domestic institutions: +0.0 points over 8 quarters to 0.0%.

Fiscal-year ends: promoters +0.0 pts from Mar 24 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 3 year-ends held.
PromotersForeign inst.Domestic inst.Public
63%46%29%12%−4.7%%58.7%0.3%0%41.0%Mar 24Mar 25Mar 26
63%46%29%12%−4.7%%58.7%0.3%0%41.0%Mar 24Mar 25Mar 26
A quiet register: no holder moved a full point in two years Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
63%46%29%12%−4.7%%58.7%0.3%0%41.0%Jun 23Dec 24Jun 26
63%46%29%12%−4.7%%58.7%0.3%0%41.0%Jun 23Dec 24Jun 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Bannari Amman Sugars Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Sugar
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Andhra Sugars LtdANDHRSUGAR 73.8/100Favorable setup87% evidence BREAKING OUT 31.7/35 Revenue 16.5% · PAT 100% · OPM change 3 pp 95% evidence 14.8/25 ROCE 8.4% · OPM 12% 95% evidence 12.9/20 P/E 11.1× · PEG — 50% evidence 14.4/20 RS sector 6.8% · RS bench 19.6% · 1Y 25.7%6 of 12 weeks ahead 100% evidence
Exact sum: 31.7 + 14.8 + 12.9 + 14.4 = 73.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2DCM Shriram LtdDCMSHRIRAM 61.0/100Mixed-positive evidence100% evidence BASING 24.3/35 Revenue 11.1% · PAT 100% · OPM change 0 pp 100% evidence 14.7/25 ROCE 11.5% · OPM 9% 100% evidence 18.3/20 P/E 11.4× · PEG 0.44 100% evidence 3.7/20 RS sector -20.5% · RS bench -10.3% · 1Y -19.6%0 of 12 weeks ahead 100% evidence
Exact sum: 24.3 + 14.7 + 18.3 + 3.7 = 61 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -20.5% and the one-year return is -19.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
3Ugar Sugar Works LtdUGARSUGAR 60.2/100Thin evidence · provisional59% evidence 26.9/35 Revenue 17.2% · PAT 100% · OPM change 4.1 pp 71% evidence 10.5/25 ROCE 9% · OPM 5.6% 76% evidence 10.6/20 P/E 21.2× · PEG — 50% evidence 12.2/20 RS sector — · RS bench 31.2% · 1Y — 25% evidence
Exact sum: 26.9 + 10.5 + 10.6 + 12.2 = 60.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Dhampur Sugar Mills LtdDHAMPURSUG 56.9/100Mixed-positive evidence87% evidence BREAKING OUT 21.3/35 Revenue 1.3% · PAT 36.3% · OPM change 1.3 pp 95% evidence 9.8/25 ROCE 6.4% · OPM 5.7% 95% evidence 10.0/20 P/E 15× · PEG — 50% evidence 15.8/20 RS sector 8% · RS bench 20.9% · 1Y 19%5 of 12 weeks ahead 100% evidence
Exact sum: 21.3 + 9.8 + 10 + 15.8 = 56.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Uttam Sugar Mills LtdUTTAMSUGAR 52.1/100Mixed-positive evidence74% evidence BREAKING OUT 16.5/35 Revenue 7.8% · PAT -7.6% · OPM change -3.7 pp 95% evidence 15.2/25 ROCE 11.4% · OPM 4.3% 95% evidence 10.9/20 P/E 12.1× · PEG — 15% evidence 9.5/20 RS sector -9.1% · RS bench 17.4% · 1Y 5.8%5 of 10 weeks ahead 70% evidence
Exact sum: 16.5 + 15.2 + 10.9 + 9.5 = 52.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6M.V.K. Agro Food Product LtdMVKAGRO 52.1/100Thin evidence · provisional57% evidence BASING 13.3/35 Revenue — · PAT — · OPM change -7.5 pp 45% evidence 17.5/25 ROCE 14.4% · OPM 10.8% 95% evidence 9.6/20 P/E 30.5× · PEG — 15% evidence 11.7/20 RS sector 33.8% · RS bench -40.7% · 1Y -19%0 of 10 weeks ahead 70% evidence
Exact sum: 13.3 + 17.5 + 9.6 + 11.7 = 52.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7Triveni Engineering and Industries LtdTRIVENI 51.9/100Mixed-positive evidence82% evidence BREAKING OUT 21.8/35 Revenue 4% · PAT 29.1% · OPM change 1 pp 95% evidence 12.2/25 ROCE 9% · OPM 3.4% 76% evidence 8.0/20 P/E 21.5× · PEG — 50% evidence 9.9/20 RS sector -1.3% · RS bench 10.7% · 1Y 16%8 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 12.2 + 8 + 9.9 = 51.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
8Avadh Sugar & Energy LtdAVADHSUGAR 51.9/100Mixed-positive evidence79% evidence BREAKING OUT 14.5/35 Revenue 4.2% · PAT -6.9% · OPM change 0.7 pp 71% evidence 10.1/25 ROCE 6.8% · OPM 4.7% 95% evidence 7.3/20 P/E 22.9× · PEG — 50% evidence 20.0/20 RS sector 51.4% · RS bench 68.4% · 1Y 69.5%9 of 12 weeks ahead 100% evidence
Exact sum: 14.5 + 10.1 + 7.3 + 20 = 51.9 · Decision use: Price leads the evidence: RS versus the benchmark is 68.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
9EID Parry (India) LtdEIDPARRY 50.3/100Mixed-positive evidence76% evidence TURNING 17.5/35 Revenue 15.7% · PAT -38.9% · OPM change -1 pp 95% evidence 18.0/25 ROCE 17% · OPM 8% 76% evidence 10.3/20 P/E 15.8× · PEG — 50% evidence 4.5/20 RS sector -20.5% · RS bench -16.7% · 1Y -35.2%1 of 10 weeks ahead 70% evidence
Exact sum: 17.5 + 18 + 10.3 + 4.5 = 50.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Balrampur Chini Mills LtdBALRAMCHIN 50.0/100Mixed-positive evidence100% evidence BREAKING OUT 15.6/35 Revenue 15% · PAT -11.2% · OPM change -2 pp 100% evidence 13.3/25 ROCE 9.3% · OPM 7% 100% evidence 2.2/20 P/E 39.4× · PEG 2.21 100% evidence 18.9/20 RS sector 22.8% · RS bench 37.4% · 1Y 25.8%11 of 12 weeks ahead 100% evidence
Exact sum: 15.6 + 13.3 + 2.2 + 18.9 = 50 · Decision use: Price leads the evidence: RS versus the benchmark is 37.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
11Dhampur Bio Organics LtdDBOL 50.0/100Mixed-positive evidence72% evidence BREAKING OUT 21.5/35 Revenue 8% · PAT 100% · OPM change -0.1 pp 71% evidence 7.2/25 ROCE 5% · OPM 1.7% 95% evidence 9.4/20 P/E 30.8× · PEG — 15% evidence 11.9/20 RS sector 7.7% · RS bench 20.4% · 1Y 39%3 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 7.2 + 9.4 + 11.9 = 50 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Dalmia Bharat Sugar & Industries LtdDALMIASUG 47.9/100Mixed-negative evidence100% evidence BREAKING OUT 7.2/35 Revenue -5.2% · PAT -44.1% · OPM change -4.4 pp 100% evidence 9.9/25 ROCE 8.2% · OPM 5.1% 100% evidence 12.9/20 P/E 16.5× · PEG 0.55 100% evidence 17.9/20 RS sector 9.7% · RS bench 22.6% · 1Y 9.7%5 of 12 weeks ahead 100% evidence
Exact sum: 7.2 + 9.9 + 12.9 + 17.9 = 47.9 · Decision use: Price leads the evidence: RS versus the benchmark is 22.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
13Zuari Industries LtdZUARIIND 39.9/100Mixed-negative evidence66% evidence TURNING 16.1/35 Revenue 9.7% · PAT 100% · OPM change -5.3 pp 71% evidence 7.6/25 ROCE 5.5% · OPM 4.5% 95% evidence 11.5/20 P/E 7× · PEG — 15% evidence 4.7/20 RS sector -26.8% · RS bench -1.7% · 1Y -9.1%4 of 10 weeks ahead 70% evidence
Exact sum: 16.1 + 7.6 + 11.5 + 4.7 = 39.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Magadh Sugar & Energy LtdMAGADSUGAR 38.8/100Mixed-negative evidence79% evidence BREAKING OUT 8.2/35 Revenue -5.7% · PAT -46.9% · OPM change -5.8 pp 71% evidence 8.5/25 ROCE 7.8% · OPM 0.2% 95% evidence 9.4/20 P/E 14.8× · PEG — 50% evidence 12.7/20 RS sector -1.5% · RS bench 10.6% · 1Y -4.3%5 of 12 weeks ahead 100% evidence
Exact sum: 8.2 + 8.5 + 9.4 + 12.7 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Davangere Sugar Company LtdDAVANGERE 37.1/100Mixed-negative evidence70% evidence 14.3/35 Revenue 11.1% · PAT -22.3% · OPM change -6.9 pp 83% evidence 10.3/25 ROCE 5.6% · OPM 10.1% 95% evidence 8.5/20 P/E 58.6× · PEG — 15% evidence 4.0/20 RS sector -25% · RS bench -12.6% · 1Y -12.3%0 of 2 weeks ahead to 2026-07-19 70% evidence
Exact sum: 14.3 + 10.3 + 8.5 + 4 = 37.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16Bannari Amman Sugars Ltdthis pageBANARISUG 35.4/100Mixed-negative evidence100% evidence ASLEEP 11.0/35 Revenue -7.6% · PAT 8% · OPM change -12 pp 100% evidence 10.2/25 ROCE 8.8% · OPM -3% 100% evidence 9.3/20 P/E 36.2× · PEG 1.75 100% evidence 4.9/20 RS sector -12.1% · RS bench -1.1% · 1Y -3.7%2 of 12 weeks ahead 100% evidence
Exact sum: 11 + 10.2 + 9.3 + 4.9 = 35.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Godavari Biorefineries LtdGODAVARIB 35.1/100Mixed-negative evidence72% evidence BASING 18.0/35 Revenue 7% · PAT 100% · OPM change -1 pp 71% evidence 7.2/25 ROCE 6.5% · OPM 0.1% 95% evidence 8.8/20 P/E 41.2× · PEG — 15% evidence 1.1/20 RS sector -24% · RS bench -14.6% · 1Y -17.7%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 7.2 + 8.8 + 1.1 = 35.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Bajaj Hindusthan Sugar LtdBAJAJHIND 32.0/100Adverse evidence78% evidence TURNING 12.8/35 Revenue -1.9% · PAT 100% · OPM change -8.9 pp 74% evidence 1.2/25 ROCE 3.1% · OPM -11% 100% evidence 10.3/20 P/E 38.6× · PEG 1.32 65% evidence 7.7/20 RS sector -21% · RS bench 12.8% · 1Y -1%4 of 11 weeks ahead 70% evidence
Exact sum: 12.8 + 1.2 + 10.3 + 7.7 = 32 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Shree Renuka Sugars LtdRENUKA 28.7/100Adverse evidence71% evidence TURNING 10.0/35 Revenue -5.1% · PAT -80% · OPM change 0.7 pp 74% evidence 0.5/25 ROCE -3.1% · OPM -3.6% 100% evidence 10.0/20 P/E — · PEG — 0% evidence 8.2/20 RS sector -12.8% · RS bench -1.8% · 1Y -22.6%2 of 12 weeks ahead 100% evidence
Exact sum: 10 + 0.5 + 10 + 8.2 = 28.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
20Dwarikesh Sugar Industries LtdDWARKESH 28.4/100Adverse evidence72% evidence TURNING 9.6/35 Revenue -4.8% · PAT -45.8% · OPM change -8 pp 71% evidence 2.5/25 ROCE 4.6% · OPM -7% 95% evidence 8.7/20 P/E 57.2× · PEG — 15% evidence 7.6/20 RS sector -3.4% · RS bench 8.2% · 1Y 0.4%2 of 12 weeks ahead 100% evidence
Exact sum: 9.6 + 2.5 + 8.7 + 7.6 = 28.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21DCM Shriram Industries LtdDCMSRIND 43.3/100Thin evidence · provisional48% evidence 12.5/35 Revenue -3.7% · PAT -50% · OPM change -6.8 pp 45% evidence 14.6/25 ROCE 13.7% · OPM 1.8% 71% evidence 8.4/20 P/E 8.2× · PEG — 50% evidence 7.8/20 RS sector — · RS bench -16.3% · 1Y — 25% evidence
Exact sum: 12.5 + 14.6 + 8.4 + 7.8 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Bannari Amman Sugars Ltd's share price today?

Bannari Amman Sugars Ltd trades at ₹3,518, −5.8% over the past year. The company is valued at ₹4,411 Cr. The stock sits at 22% of its 52-week range of ₹3,378–₹4,020, −2.7% versus its 200-day average. On the tape, the price is in a downtrend, 10 weeks in. — as of 11 September 2026.

What were Bannari Amman Sugars Ltd's latest quarterly results?

Bannari Amman Sugars Ltd reported revenue of ₹172 Cr and a net loss of ₹11.0 Cr for the Jun 26 quarter. Revenue fell 58.9% and profit fell 173.3% year on year. Earnings per share were ₹−8.71. The operating margin was −3.0%, 12.0 pp lower than a year earlier. — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's revenue?

Bannari Amman Sugars Ltd reported revenue of ₹172 Cr in the Jun 26 quarter, −58.9% year on year. For the full FY26 fiscal year, revenue was ₹1,917 Cr (+6.9%). Over the last 10 years revenue compounded at 2.8% a year. — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's profit?

Bannari Amman Sugars Ltd earned ₹−11.0 Cr of net profit in the Jun 26 quarter, −173.3% year on year. Full-year FY26 profit was ₹148 Cr. The operating margin ran −3.0% in the latest quarter. — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's market cap?

Bannari Amman Sugars Ltd's market capitalisation is ₹4,411 Cr at a share price of ₹3,518. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's P/E ratio?

Bannari Amman Sugars Ltd trades at a P/E of 36.2×, at the 82nd percentile of its own 10-year range, against a long-run median of 24.9×. This is a comparison with the stock's own history, not a value call — as of 11 September 2026.

Does Bannari Amman Sugars Ltd pay a dividend?

Yes — Bannari Amman Sugars Ltd's dividend payout was 11% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 11 September 2026.

Is Bannari Amman Sugars Ltd overvalued?

On its own history, Bannari Amman Sugars Ltd looks expensive: its P/E of 36.2× sits at the 82nd percentile of its 10-year range (long-run median 24.9×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 11 September 2026.

Is Bannari Amman Sugars Ltd growing?

Not right now — Bannari Amman Sugars Ltd's latest numbers are shrinking: latest-quarter revenue −58.9% year on year, profit −173.3%, and the margin −12.0 pp at −3.0%. The 10-year compound rates are 2.8% (revenue) and 16.5% (profit). The earnings engine currently reads: deteriorating — as of 11 September 2026.

How is Bannari Amman Sugars Ltd performing?

Bannari Amman Sugars Ltd is in a downtrend, 10 weeks in. Its latest quarter's revenue fell 58.9% and profit fell 173.3% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 4 weeks. This describes what the data did, not a rating. — as of 11 September 2026.

What stage is Bannari Amman Sugars Ltd in?

Turning around — profit growth swung from −32.0% at the trough to +8.0% off a 5-quarter-old trough, ROCE holding at 9.0%. The read comes from the last 12 quarters of growth (revenue growth −7.6% latest, profit growth +8.0% latest, eps growth +7.3% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 11 September 2026.

Is Bannari Amman Sugars Ltd in an uptrend?

No — the price is in a downtrend (week 10 of stage 4), trading −2.7% versus its 200-day average and at 22% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 11 September 2026.

Is Bannari Amman Sugars Ltd beating the market?

On recent form, yes — Bannari Amman Sugars Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 4 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.5 years the stock moved +190% against the NIFTY 500's +267% — behind the index over the full window. — as of 11 September 2026.

Will Bannari Amman Sugars Ltd's share price go up?

This page publishes no price forecast for Bannari Amman Sugars Ltd. What it measures instead: the share price is ₹3,518, the price is in a downtrend 10 weeks in. Its P/E of 36.2× sits at the 82nd percentile of its own 10-year range. — as of 11 September 2026.

Who owns Bannari Amman Sugars Ltd?

Promoters hold 58.7% of Bannari Amman Sugars Ltd, foreign institutions 0.3%, domestic institutions null% and the public 41.0% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 11 September 2026.

Does Bannari Amman Sugars Ltd have too much debt?

No — Bannari Amman Sugars Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill 99×. FY26 borrowings were ₹9.0 Cr against equity of ₹1,914 Cr. The returns on this page are earned, not borrowed — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's capex?

Bannari Amman Sugars Ltd spent ₹329 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹112 Cr, with ₹106 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 11 September 2026.

What is Bannari Amman Sugars Ltd's cash flow?

Bannari Amman Sugars Ltd generated ₹514 Cr of operating cash flow in FY26 and ₹402 Cr of free cash flow after ₹112 Cr of capital spending. Reported profit that year was ₹148 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 11 September 2026.

Is Bannari Amman Sugars Ltd's profit real cash?

Yes — over the last 3 fiscal years, 301% of Bannari Amman Sugars Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹514 Cr against reported profit of ₹148 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 11 September 2026.

Where is Bannari Amman Sugars Ltd in its business cycle?

Bannari Amman Sugars Ltd's FY26 operating margin was 10.0%, against a 13-year band of 10.0%–23.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −3.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 11 September 2026.

What could break the Bannari Amman Sugars Ltd story?

The sharpest disagreement: annual EPS moved +41.3% against a −5.8% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 11 September 2026.

Is Bannari Amman Sugars Ltd a stock worth studying right now?

This is not investment advice. The machine read: Bannari Amman Sugars Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 11 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-11. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI